Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthma.

Author: HaughneyJohn, KocksJanwillem W H, MingSimon Wan Yau, OchelMatthias, PatelShishir, PriceDavid, RyanDermot, ThornhillSusannah, d'AlcontresMartina Stagno

Paper Details 
Original Abstract of the Article :
Co-prescription of Aerochamber<sup>&#174;</sup> spacer with non-extrafine beclometasone diproprionate (non-EF BDP) is common but unlicensed. We report a comparison of inhaled corticosteroid (ICS)-related adverse events between patients co-prescribed Aerochamber compared to the licensed Volumatic<sup...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368625/

データ提供:米国国立医学図書館(NLM)

Spacer Use with Beclometasone Dipropionate for Asthma

Asthma, a chronic respiratory condition, can feel like a suffocating sandstorm, making it difficult to breathe. This research examines the safety of using different spacers with beclometasone dipropionate, a common inhaled corticosteroid used for asthma management. The authors conducted a comparative study using two historical cohorts, analyzing patient-reported and electronic medical record (EMR) data to assess the incidence of adverse events associated with different spacer types. Their findings revealed no significant difference in the risk of adverse events between patients using Aerochamber and Volumatic spacers. This research provides valuable insights into the safety of spacer use with beclometasone dipropionate, offering reassurance to patients and healthcare providers.

Spacer Use with Beclometasone Dipropionate: A Safe Approach for Asthma Management

This research demonstrates that using different spacers with beclometasone dipropionate does not significantly increase the risk of adverse events. It's like finding a safe and reliable path through the desert of asthma management, ensuring that treatment options are not only effective but also safe.

Managing Asthma: Finding the Right Tools for the Journey

This research highlights the importance of using appropriate tools for asthma management, including spacers, to ensure safe and effective treatment. It's like having the right equipment and supplies for a journey through the desert, ensuring a smooth and successful journey. Healthcare providers can work with patients to find the best combination of medication and delivery devices to achieve optimal asthma control.

Dr. Camel's Conclusion

This research provides reassuring findings regarding the safety of using different spacers with beclometasone dipropionate for asthma management. It's like discovering a hidden oasis in the vast desert of asthma treatments, offering a safe and reliable haven for patients seeking relief from their symptoms. This research emphasizes the importance of collaborating with healthcare providers to find the best tools and strategies for managing asthma, ensuring a smoother and more comfortable journey through the desert of this chronic condition.
Date :
  1. Date Completed 2020-08-26
  2. Date Revised 2020-08-26
Further Info :

Pubmed ID

30737400

DOI: Digital Object Identifier

PMC6368625

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.